MindWalk Holdings (HYFT) Assets Average (2021 - 2026)
MindWalk Holdings (HYFT) posted quarterly Assets Average of $16.1 million for Q2 2026, down 49.2% year-over-year from $31.7 million in Q2 2025, and down 9.11% quarter-over-quarter from $17.7 million in Q1 2026.
MindWalk Holdings (HYFT) Assets Average (2021 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Assets Average for 6 consecutive years, with $16.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Assets Average fell 49.2% year-over-year to $16.1 million; the TTM figure through Apr 2026 stood at $16.1 million (down 49.2% YoY), while the FY2026 annual figure was $23.7 million, down 37.79% from the prior year.
- Assets Average retreated to $16.1 million in Q2 2026 per HYFT's latest filing, from $17.7 million in the prior quarter.
- Across five years, Assets Average topped out at $68.0 million in Q3 2022 and bottomed at $16.1 million in Q2 2026.
- Historically, Assets Average has averaged $45.8 million across 5 years, with a median of $48.8 million in 2022.
- Annual changes were most pronounced in 2022 — Assets Average jumped 38.3% — and 2026, when it plunged 53.44%.
- MindWalk Holdings' Assets Average stood at $62.2 million in 2022, then declined by 9.1% to $56.6 million in 2023, then decreased by 22.91% to $43.6 million in 2024, then plunged by 44.42% to $24.2 million in 2025, then slumped by 33.66% to $16.1 million in 2026.
- Business Quant data shows HYFT's Assets Average at $16.1 million in Q2 2026, $17.7 million in Q1 2026, and $24.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 5.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 16.08 Mn |
| Jan 31, 2026 | 17.69 Mn |
| Oct 31, 2025 | 24.24 Mn |
| Jul 31, 2025 | 30.44 Mn |
| Apr 30, 2025 | 31.65 Mn |
| Jan 31, 2025 | 37.99 Mn |
| Oct 31, 2024 | 43.61 Mn |
| Jul 31, 2024 | 43.77 Mn |
| Apr 30, 2024 | 51.22 Mn |
| Jan 31, 2024 | 56.98 Mn |
| Oct 31, 2023 | 56.57 Mn |
| Jul 31, 2023 | 57.44 Mn |
| Apr 30, 2023 | 59.31 Mn |
| Jan 31, 2023 | 61.71 Mn |
| Oct 31, 2022 | 62.23 Mn |
| Jul 31, 2022 | 68.05 Mn |
| Apr 30, 2022 | 59.27 Mn |
| Jan 31, 2022 | 46.29 Mn |
| Oct 31, 2021 | 50.22 Mn |
| Jul 31, 2021 | 52.82 Mn |